PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer.

MLA

Ghosh, Mithun, et al. “PSPC1 Inhibition Synergizes with Poly(ADP-Ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer.” International Journal of Molecular Sciences, vol. 24, no. 23, Dec. 2023, p. 17086. EBSCOhost, https://doi.org/10.3390/ijms242317086.

APA

Ghosh, M., Kang, M. S., Katuwal, N. B., Hong, S. D., Jeong, Y. G., Park, S. M., Kim, S.-G., & Moon, Y. W. (2023). PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer. International Journal of Molecular Sciences, 24(23), 17086. https://doi.org/10.3390/ijms242317086

Chicago

Ghosh, Mithun, Min Sil Kang, Nar Bahadur Katuwal, Sa Deok Hong, Yeong Gyu Jeong, Seong Min Park, Seul-Gi Kim, and Yong Wha Moon. 2023. “PSPC1 Inhibition Synergizes with Poly(ADP-Ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer.” International Journal of Molecular Sciences 24 (23): 17086. doi:10.3390/ijms242317086.